Gene info: ID 51312

SNP ID	Position	Alleles	Trait	Variation Type
rs17089358	chr8:23553762 (GRCh38.p7)	T>C	alcohol dependence	SNV(Single Nucleotide Variation)

Gene Symbol	Pearson Correlation Coefficient
STAT3	0.836
SHC1	0.836
HDAC7	0.827
NUP98	0.802
TBC1D2B	0.802
PATL1	0.796
IL18BP	0.793
SERPINB9	0.791
SBNO2	0.79
NUP205	0.789

Gene Symbol	Pearson Correlation Coefficient
OR4F5	-0.434
OR4F29	-0.414
CPLX3	-0.264
HES5	-0.25
MYCNOS	-0.237
CRH	-0.236
ACY3	-0.224
ZNRF4	-0.222
SNX22	-0.209
ARSF	-0.207

DrugBank
CTD

There is no DrugBank record for this gene !

ID	Drug Name	Action	PubMed
C026486	1,2,5,6-dibenzanthracene	"1,2,5,6-dibenzanthracene results in decreased expression of SLC25A37 mRNA"	26377693
C472829	1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole	"1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC25A37 mRNA"	27071940
C472829	1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole	"NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC25A37 mRNA]"	27071940
C028474	1,4-bis(2-(3,5-dichloropyridyloxy))benzene	"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of SLC25A37 mRNA"	21354444\|2890350
C051246	1-methylanthracene	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA	28329830
C006593	2-anthramine	2-anthramine results in increased expression of SLC25A37 mRNA	23038007
C472791	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of SLC25A37 mRNA	12958071
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA"	27188386
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA"	27188386
D000082	Acetaminophen	Acetaminophen results in decreased expression of SLC25A37 mRNA	21420995
D016604	Aflatoxin B1	Aflatoxin B1 results in increased methylation of SLC25A37 gene	28458013
D017638	Asbestos, Crocidolite	"Asbestos, Crocidolite affects the expression of SLC25A37 mRNA"	24160326
D001280	Atrazine	Atrazine results in increased expression of SLC25A37 mRNA	22378314
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of SLC25A37 mRNA	26001963
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of SLC25A37 mRNA	26238291
D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLC25A37 mRNA"	19150397\|2001819
D004958	Estradiol	[bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA	26496021
C006780	bisphenol A	bisphenol A affects the expression of SLC25A37 mRNA	21786754
C006780	bisphenol A	bisphenol A affects the expression of SLC25A37 mRNA	25181051
C006780	bisphenol A	[bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA	26496021
C006780	bisphenol A	[bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA	26496021
D002110	Caffeine	Caffeine results in decreased expression of SLC25A37 mRNA	20864626
C099555	CD 437	CD 437 results in decreased expression of SLC25A37 mRNA	12958071
C018021	cobaltous chloride	cobaltous chloride results in increased expression of SLC25A37 mRNA	19376846
C018021	cobaltous chloride	cobaltous chloride results in increased expression of SLC25A37 mRNA	24386269
D003042	Cocaine	Cocaine results in increased expression of SLC25A37 mRNA	15009677\|1671032
D003300	Copper	[Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA	24690739
D019327	Copper Sulfate	Copper Sulfate results in increased expression of SLC25A37 mRNA	19549813
D003375	Coumestrol	Coumestrol results in decreased expression of SLC25A37 mRNA	19167446
D016572	Cyclosporine	Cyclosporine results in increased expression of SLC25A37 mRNA	25562108
D016572	Cyclosporine	Cyclosporine results in decreased expression of SLC25A37 mRNA	19770486
C093628	cyproconazole	cyproconazole results in increased expression of SLC25A37 mRNA	22334560
D003703	Demecolcine	Demecolcine results in decreased expression of SLC25A37 mRNA	23649840
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased expression of SLC25A37 mRNA	21266533
D004026	Dieldrin	Dieldrin results in increased expression of SLC25A37 mRNA	28385952
D004221	Disulfiram	[Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA	24690739
C118739	entinostat	entinostat results in decreased expression of SLC25A37 mRNA	26272509
C118739	entinostat	"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA"	27188386
C109476	epoxiconazole	epoxiconazole results in increased expression of SLC25A37 mRNA	22334560
D004997	Ethinyl Estradiol	Ethinyl Estradiol affects the expression of SLC25A37 mRNA	17555576
D005020	Ethyl Methanesulfonate	Ethyl Methanesulfonate results in decreased expression of SLC25A37 mRNA	23649840
C007738	fluoranthene	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA	28329830
D005485	Flutamide	Flutamide results in increased expression of SLC25A37 mRNA	24136188
D003932	Heroin	Heroin results in increased expression of SLC25A37 mRNA	16710320
C492448	ICG 001	ICG 001 affects the expression of SLC25A37 mRNA	26191083
C410337	K 7174	K 7174 results in increased expression of SLC25A37 mRNA	24086573
C013598	methoxyacetic acid	methoxyacetic acid results in decreased expression of SLC25A37 mRNA	20864626
C004925	methylmercuric chloride	methylmercuric chloride results in decreased expression of SLC25A37 mRNA	20864626
D008741	Methyl Methanesulfonate	Methyl Methanesulfonate results in increased expression of SLC25A37 mRNA	26011545
D008741	Methyl Methanesulfonate	Methyl Methanesulfonate results in decreased expression of SLC25A37 mRNA	23649840
D018817	N-Methyl-3,4-methylenedioxyamphetamine	"N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC25A37 mRNA"	20188158
C028577	monobutyl phthalate	monobutyl phthalate results in decreased expression of SLC25A37 mRNA	20864626
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in decreased expression of SLC25A37 mRNA"	25554681\|2562005
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in decreased expression of SLC25A37 mRNA"	25554681\|2562005
C017096	n-butoxyethanol	n-butoxyethanol results in increased expression of SLC25A37 mRNA	19812364
C009618	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	"PON1 gene polymorphism affects the susceptibility to [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the expression of SLC25A37 mRNA]"	21673326
C030110	oxaliplatin	[oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA	25729387
C030110	oxaliplatin	oxaliplatin results in decreased expression of SLC25A37 mRNA	25729387
D010634	Phenobarbital	Phenobarbital affects the expression of SLC25A37 mRNA	23091169
D010634	Phenobarbital	Phenobarbital results in increased expression of SLC25A37 mRNA	19270015
C006253	pirinixic acid	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A37 mRNA	19710929
C006253	pirinixic acid	pirinixic acid results in decreased expression of SLC25A37 mRNA	18445702
C006253	pirinixic acid	pirinixic acid results in increased expression of SLC25A37 mRNA	18301758
D010938	Plant Oils	Plant Oils results in decreased expression of SLC25A37 mRNA	23370395
D011078	Polychlorinated Biphenyls	Polychlorinated Biphenyls affects the expression of SLC25A37 mRNA	21334430
C027373	potassium chromate(VI)	potassium chromate(VI) results in decreased expression of SLC25A37 mRNA	22714537
D011285	Pregnenolone Carbonitrile	Pregnenolone Carbonitrile results in increased expression of SLC25A37 mRNA	28903501
C045950	propiconazole	propiconazole results in increased expression of SLC25A37 mRNA	21278054\|2233456
D011441	Propylthiouracil	Propylthiouracil results in decreased expression of SLC25A37 mRNA	24780913
C059514	resveratrol	resveratrol results in increased expression of SLC25A37 mRNA	22610192
D012643	Selenium	Selenium results in increased expression of SLC25A37 mRNA	19244175
D017632	Asbestos, Serpentine	"Asbestos, Serpentine affects the expression of SLC25A37 mRNA"	24160326
D012822	Silicon Dioxide	Silicon Dioxide results in decreased expression of SLC25A37 mRNA	19073995
C017947	sodium arsenite	sodium arsenite affects the expression of SLC25A37 mRNA	29319823
C017947	sodium arsenite	sodium arsenite results in decreased expression of SLC25A37 mRNA	22714537
D013629	Tamoxifen	Tamoxifen affects the expression of SLC25A37 mRNA	17555576
D013629	Tamoxifen	Tamoxifen results in increased expression of SLC25A37 mRNA	17555576
D013739	Testosterone	[bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA	26496021
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of SLC25A37 mRNA	25172293
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of SLC25A37 mRNA	21570461
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA	19770486
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of SLC25A37 mRNA	28213091
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA	21215274
C009495	titanium dioxide	titanium dioxide results in increased expression of SLC25A37 mRNA	23557971
D019772	Topotecan	[oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA	25729387
D019772	Topotecan	Topotecan results in decreased expression of SLC25A37 mRNA	25729387
D014212	Tretinoin	Tretinoin results in increased expression of SLC25A37 mRNA	17218384
C015559	trimellitic anhydride	trimellitic anhydride results in increased expression of SLC25A37 mRNA	19042947
C016805	tris(1,3-dichloro-2-propyl)phosphate	"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of SLC25A37 mRNA"	26179874
C406224	valdecoxib	valdecoxib results in increased expression of SLC25A37 mRNA	24136188
D014635	Valproic Acid	Valproic Acid results in increased expression of SLC25A37 mRNA	24935251\|2915479
D014638	Vanadates	Vanadates results in increased expression of SLC25A37 mRNA	22714537
D001335	Vehicle Emissions	Vehicle Emissions results in decreased methylation of SLC25A37 gene	25560391
D014750	Vincristine	Vincristine results in decreased expression of SLC25A37 mRNA	23649840
D015032	Zinc	Zinc deficiency results in increased expression of SLC25A37 mRNA	18356318

Reactome ID	Reactome Term	Evidence
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	IEA
R-HSA-1430728	Metabolism	IEA

Gene: SLC25A37

ANCO-SNPs

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Top 10 negatively co-expressed genes

Drugs/Compounds

There is no DrugBank record for this gene !

GO/Pathway

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)